BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 26864666)

  • 1. Evaluation of the local carcinogenic potential of mesh used in the treatment of female stress urinary incontinence.
    Linder BJ; Trabuco EC; Carranza DA; Gebhart JB; Klingele CJ; Occhino JA
    Int Urogynecol J; 2016 Sep; 27(9):1333-6. PubMed ID: 26864666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there an association between polypropylene midurethral slings and malignancy?
    King AB; Zampini A; Vasavada S; Moore C; Rackley RR; Goldman HB
    Urology; 2014 Oct; 84(4):789-92. PubMed ID: 25260443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of vaginal mesh exposure after midurethral sling placement: a case-control study.
    Linder BJ; El-Nashar SA; Carranza Leon DA; Trabuco EC
    Int Urogynecol J; 2016 Sep; 27(9):1321-6. PubMed ID: 26811112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of transurethral resection (TUR) of intravesical mesh after suburethral slings in the treatment of urinary stress incontinence.
    Castroviejo-Royo F; Rodríguez-Toves LA; Martínez-Sagarra-Oceja JM; Conde-Redondo C; Mainez-Rodríguez JA
    Actas Urol Esp; 2015 Apr; 39(3):183-7. PubMed ID: 25457565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Autologous Fascia Pubovaginal Sling for Patients with Transvaginal Mesh Related Complications Requiring Mesh Removal.
    McCoy O; Vaughan T; Nickles SW; Ashley M; MacLachlan LS; Ginsberg D; Rovner E
    J Urol; 2016 Aug; 196(2):484-9. PubMed ID: 26997314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenging the Myth: Transvaginal Mesh is Not Associated with Carcinogenesis.
    Chughtai B; Sedrakyan A; Mao J; Thomas D; Eilber KS; Clemens JQ; Anger JT
    J Urol; 2017 Oct; 198(4):884-889. PubMed ID: 28479238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incontinence rates after midurethral sling revision for vaginal exposure or pain.
    Jambusaria LH; Heft J; Reynolds WS; Dmochowski R; Biller DH
    Am J Obstet Gynecol; 2016 Dec; 215(6):764.e1-764.e5. PubMed ID: 27448731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sling Plication for Failed Midurethral Sling Procedures: A Case Series.
    Maheshwari D; Jones K; Solomon E; Harmanli O
    Female Pelvic Med Reconstr Surg; 2019; 25(1):e4-e6. PubMed ID: 30180049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for mesh erosion after vaginal sling procedures for urinary incontinence.
    Kokanali MK; Doğanay M; Aksakal O; Cavkaytar S; Topçu HO; Özer İ
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():146-50. PubMed ID: 24793930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of urinary fistulas due to midurethral sling surgery.
    Blaivas JG; Mekel G
    J Urol; 2014 Oct; 192(4):1137-42. PubMed ID: 24742595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystolith formation complicating single-incision sling.
    Chin K; Ripperda CM; Schaffer JI; Wai CY
    Female Pelvic Med Reconstr Surg; 2014; 20(3):177-9. PubMed ID: 24763161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Risk After Midurethral Sling Surgery Using Polypropylene Mesh.
    Altman D; Rogers RG; Yin L; Tamussino K; Ye W; Iglesia CB
    Obstet Gynecol; 2018 Mar; 131(3):469-474. PubMed ID: 29420401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant trocar-guided transvaginal mesh surgery with a midurethral sling in treating advanced pelvic organ prolapse associated with stress or occult stress urinary incontinence.
    Wu CJ; Chuang FC; Chu LC; Kung FT; Huang KH; Wu MP
    Taiwan J Obstet Gynecol; 2013 Dec; 52(4):516-22. PubMed ID: 24411036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal erosion after hybrid midurethral sling placement.
    Bong GW; Rovner ES
    Urology; 2006 Dec; 68(6):1343.e13-4. PubMed ID: 17141829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomical and functional results of pubovaginal sling procedure using polypropylene mesh for the treatment of stress urinary incontinence.
    Kuo HC
    J Urol; 2001 Jul; 166(1):152-7. PubMed ID: 11435845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of lower urinary mesh perforation after mid-urethral polypropylene mesh sling: mesh excision, urinary tract reconstruction and concomitant pubovaginal sling with autologous rectus fascia.
    Shah K; Nikolavsky D; Gilsdorf D; Flynn BJ
    Int Urogynecol J; 2013 Dec; 24(12):2111-7. PubMed ID: 23824269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prolene mesh sling in the treatment of stress urinary incontinence. Integral treatment of pelvic floor anomalies. Long-term results].
    Romero Maroto J; Prieto Chaparro L; López López C; Quilez Fenoll JM; Bolufer Nadal S
    Arch Esp Urol; 2002 Nov; 55(9):1057-74. PubMed ID: 12564066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenic potential of polypropylene mid-urethral slings: what do we know so far?
    Adel E; Shapiro R; Zaslau S
    Int Urogynecol J; 2017 May; 28(5):657-660. PubMed ID: 27738738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of prophylactic retropubic sling at the time of vaginal prolapse surgery.
    Mou T; Cadish LA; Gray EL; Bretschneider CE
    Am J Obstet Gynecol; 2022 Sep; 227(3):471.e1-471.e7. PubMed ID: 35644248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications and risk factors for midurethral sling revision.
    Unger CA; Rizzo AE; Ridgeway B
    Int Urogynecol J; 2016 Jan; 27(1):117-22. PubMed ID: 26134541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.